| Bioactivity | Lidoflazine is a high affinity blocker of the HERG (human ether-a-go-go-related gene) K+ channel. Lidoflazine is an antianginal calcium channel blocker that carries a significant risk of QT interval prolongation and ventricular arrhythmia[1]. | ||||||||||||
| Invitro | Lidoflazine inhibits potently HERG current (IHERG) recorded from HEK 293 cells stably expressing wild-type HERG (IC50 of ~16 nM). | ||||||||||||
| Name | Lidoflazine | ||||||||||||
| CAS | 3416-26-0 | ||||||||||||
| Formula | C30H35F2N3O | ||||||||||||
| Molar Mass | 491.62 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. https://www.ncbi.nlm.nih.gov/pubmed/15135665 |
Lidoflazine
CAS: 3416-26-0 F: C30H35F2N3O W: 491.62
Lidoflazine is a high affinity blocker of the HERG (human ether-a-go-go-related gene) K+ channel. Lidoflazine is an anti
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.